Queen Elizabeth Hospital Birmingham

Hippocampal neurons code individual episodic memories in humans (2023) Kolibius LD, Roux F, Parish G, Ter Wal M, Van Der Plas M, Chelvarajah R, Sawlani V, et al. Journal article Oscillations support short latency co-firing of neurons during human episodic memory formation (2022) Roux F, Parish G, Chelvarajah R, Rollings DT, Sawlani V, Hamer H, Gollwitzer S, et al. Journal article Auswirkungen eines verkurzten Dosierungsintervalls von Lanreotid-Autogel (LAN) auf die Tumorwachstumsrate ( TGR) bei Patienten mit fortgeschrittenen Neuroendokrinen Tumoren (NETs) in der prospektiven, einarmigen, Phase 2 Studie CLARINET FORTE (2022) Pape UF, Dromain C, Cwikla JB, Lombard-Bohas C, Borbath I, Shah T, Capdevilla J, et al. Conference contribution Cardiopulmonary exercise testing excludes significant disease in patients recovering from COVID-19 (2022) Holdsworth DA, Barker-Davies RM, Chamley RR, O'Sullivan O, Ladlow P, May S, Houston AD, et al. Journal article Theta rhythmicity governs human behavior and hippocampal signals during memory-dependent tasks (2021) Ter Wal M, Linde-Domingo J, Lifanov J, Roux F, Kolibius LD, Gollwitzer S, Lang J, et al. Journal article Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results (2021) Pavel ME, Ćwikła JB, Lombard-Bohas C, Borbath I, Shah T, Pape UF, Capdevila J, et al. Journal article Lanreotide Autogel (LAN) 120 mg Every 14 Days in Progressive Pancreatic Neuroendocrine Tumors (panNETs): CLARINET FORTE Study (2021) Pavel ME, Cwikla J, Lombard-Bohas C, Borbath I, Shah T, Pape UF, Thanh XMT, et al. Conference contribution Efficacy, safety and quality of life (QoL) with Lanreotide Autogel (LAN) 120 mg every 14 days in progressive pancreatic or midgut neuroendocrine tumors (NETs): CLARINET FORTE study results (2021) Pavel ME, Cwikla JB, Lombard-Bohas C, Borbath , Shah T, Pape UF, Thanh TXM, et al. Conference contribution Pituitary society expert Delphi consensus: operative workflow in endoscopic transsphenoidal pituitary adenoma resection (2021) Marcus HJ, Khan DZ, Borg A, Buchfelder M, Cetas JS, Collins JW, Dorward NL, et al. Journal article Efficacy and safety of lanreotide autogel (LAN) 120 mg every 14 days in progressive pancreatic or midgut neuroendocrine tumours (NETs): CLARINET FORTE study results (2020) Pavel ME, Cwikla JB, Lombard-Bohas C, Borbath I, Shah T, Pape UF, Thanh XMT, et al. Conference contribution